Pazopanib (P) and cisplatin (CDDP) in patients with advanced solid tumors: A UNICANCER phase I study.

被引：2
|
作者：
Dieras, Veronique
Bachelot, Thomas
Campone, Mario
Isambert, Nicolas
Joly, Florence
Le Toumeau, Chrlstophe
Cassler, Philippe Alexandre
Bompas, Emmanuelle
Fumoloau, Pierre
Noal, Sabine
Orsini, Christina
Jimenez, Marta
Imbs, Diane Charlotte
Chatelut, Etienne
机构：
[1] Inst Curie, Paris, France
[2] Ctr Leon Berard, F-69373 Lyon, France
[3] Inst Cancerol Ouest, Nantes, France
[4] Ctr Georges Francois Leclerc, Dijon, France
[5] Ctr Francois Baclesse, Dept Med Oncol, F-14021 Caen, France
[6] Inst Curie, Dept Med Oncol, Paris, France
[7] Inst Cancerol Ouest, Dept Med Oncol, Nantes, France
[8] Ctr Francois Baclesse, F-14021 Caen, France
[9] UNICANCER, Paris, France
[10] Inst Claudius Regaud, Toulouse, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.2583
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2583
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Phase I and pharmacokinetic (PK) study of pazopanib (P) in combination with two schedules of ifosfamide (I) in patients (pts) with advanced solid tumors (STs).
    Hamberg, Paul
    Boers-Sonderen, Marye
    Loos, Walter J.
    De Jonge, Maja J.
    Van der Graaf, Winette T. A.
    Suttle, Ben B.
    Eskens, Ferry
    Verweij, Jaap
    Van Herpen, Carla
    Sleijfer, Stefan
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [22] Phase I study of pazopanib plus TH-302 in advanced solid tumors
    Riedel, Richard F.
    Meadows, Kellen L.
    Lee, Paula H.
    Morse, Michael A.
    Uronis, Hope E.
    Blobe, Gerard C.
    George, Daniel J.
    Crawford, Jeffrey
    Niedzwiecki, Donna
    Rushing, Christel N.
    Arrowood, Christy C.
    Hurwitz, Herbert I.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 79 (03) : 611 - 619
  • [23] A phase I study of pazopanib with weekly paclitaxel and carboplatin in advanced solid tumors.
    Chan, Nancy
    Portal, Daniella E.
    Moss, Rebecca Anne
    Silk, Ann W.
    Stein, Mark N.
    Aisner, Joseph
    Malhotra, Jyoti
    Shih, Weichung
    Lin, Hongxia
    Kane, Michael P.
    Mehnert, Janice M.
    Tan, Antoinette R.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [24] Phase I study of pazopanib plus TH-302 in advanced solid tumors
    Richard F. Riedel
    Kellen L. Meadows
    Paula H. Lee
    Michael A. Morse
    Hope E. Uronis
    Gerard C. Blobe
    Daniel J. George
    Jeffrey Crawford
    Donna Niedzwiecki
    Christel N. Rushing
    Christy C. Arrowood
    Herbert I. Hurwitz
    Cancer Chemotherapy and Pharmacology, 2017, 79 : 611 - 619
  • [25] A phase I study of the safety, tolerability and pharmacokinetics of pazopanib (P) in combination with gemcitabine (G) for advanced solid tumors
    Richly, H.
    Rubin, S. D.
    Madi, A.
    Jeffels, M.
    Nokay, B.
    Gibson, D.
    Weller, S.
    Scheulen, M. E.
    Plummer, R.
    EJC SUPPLEMENTS, 2010, 8 (07): : 25 - 25
  • [26] Phase I And pharmacokinetic study of irofulven (IROF) in combination with cisplatin (CDDP), given every 2 weeks, in patients (pts) with advanced solid tumors.
    Hilgers, W
    Alexandre, J
    Tourani, JM
    Misset, JL
    Goldwasser, F
    Bourgeois, H
    Faivre, S
    Kahatt, C
    Cvitkovic, E
    Weems, G
    Raymond, E
    CLINICAL CANCER RESEARCH, 2003, 9 (16) : 6080S - 6080S
  • [27] Phase I study of weekly irinotecan combined with weekly cisplatin in patients with advanced solid tumors
    Nakanishi, Y
    Takayama, K
    Wataya, H
    Izumi, M
    Minami, T
    Takano, K
    Inoue, K
    Osaki, S
    Kimotsuki, K
    Harada, T
    Hara, N
    CHEMOTHERAPY, 2002, 48 (04) : 205 - 210
  • [28] Phase I study of pegylated liposomal doxorubicin, paclitaxel, and cisplatin in patients with advanced solid tumors
    Eng, C
    Mauer, AM
    Fleming, GF
    Bertucci, D
    Rotmensch, J
    Jacobs, RH
    Ratain, MJ
    ANNALS OF ONCOLOGY, 2001, 12 (12) : 1743 - 1747
  • [29] Phase I study of safety, tolerability, and pharmacokinetics of pazopanib in combination with oral topotecan in patients with advanced solid tumors
    Kerklaan, Bojana Milojkovic
    Lolkema, Martijn P. J. K.
    Devriese, Lot A.
    Voest, Emile E.
    Nol-Boekel, A.
    Mergui-Roelvink, M.
    Mykulowycz, Kristine
    Stoebenau, Joseph E.
    Fang, Lei
    Legenne, Philippe
    Wissel, Paul Stephen
    Smith, Deborah A.
    Giantonio, Bruce J.
    Schellens, Jan H. M.
    Witteveen, Petronella
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [30] A phase I trial of lurbinectedin in combination with cisplatin in patients with advanced solid tumors
    Metaxas, Yannis
    Kahatt, Carmen
    Alfaro, Vicente
    Fudio, Salvador
    Zeaiter, Ali
    Plummer, Ruth
    Sessa, Cristiana
    Von Moos, Roger
    Forster, Martin
    Stathis, Anastasios
    INVESTIGATIONAL NEW DRUGS, 2022, 40 (01) : 91 - 98
12345